Sort by 'shares'
ASH 2020 Updates: CAR T Cell Therapies in Multiple Myeloma
We kickstart the new year with a discussion on CAR T cells in myeloma treatment with a focus on the CT053, a CAR T-cell therapy targeting the BCMA protein and granted orphan drug status by the U.S. Food and Drug…
COVID-19 Vaccines – A Practical Dilemma for Pregnant & Breastfeeding Women & Those Trying to Conceive
Covid19 vaccines roll out began in mid December 2020, with the Moderna and Pfizer-BioNTech vaccines as the first widely available shots. However these vaccines use the mRNA technology for which there is virtually no data - and will likely not…
PCOS & Menstrual Cycle – A PCOS Community Q&A Session
PCOS is an enigmatic disease with the most common symptoms being irregular menstrual cycles and ovulation leading to infertility in many cases. We created a PCOS Tracker, a free app for women to track their PCOS symptoms, and as it…
Nanotechnology in Oncology
What is nanotechnology and how is this field of technology revolutionizing drug delivery and cancer treatment approach? The Director of National Cancer Institute and Nanotechnology Characterization Laboratory Dr. Anil Patri discuss some of the advantages of having nanotechnolgy as an…
Dr. Carl June’s CAR-T Cell Journey and the Cancer Treatment Revolution
FDA approval of the breakthrough CAR-T cell therapy for cancer brings the first approved gene therapy treatment to the United States. It reprograms the body's own immune system to recognize and kill cancer cells. The therapy initially called CAR-T cell…